This article is more than 5 years old. Information may no longer be current.

Xen gel stent ‘transformative’ to glaucoma practice

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW ORLEANS ― At the American Academy of Ophthalmology meeting here, Nathan Radcliffe, MD, of New York Eye and Ear, discusses his implementation of the Allergan Xen gel stent for treating patients with refractory glaucoma or those in need of a minimally invasive glaucoma procedure to lower IOP.